Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



   * Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Advanced Medical Optics recalls contact lens solution

Nov 22, 2006 | AP

Eye care products maker Advanced Medical Optics Inc. is recalling U.S. batches of its Complete MoisturePlus multipurpose contact lens solution and Active Packs after finding bacterial contamination in three lots made at the same plant in China and distributed in Japan.

The Santa Ana, Calif.-based company said it has not received any reports of adverse health events associated with the 18 recalled product lots in the U.S.

Advanced Medical Optics said it withdrew affected products from the market in Japan earlier and alerted regulatory authorities worldwide including the U.S. Food and Drug Administration.

Tainted solution could cause an eye infection, the company said. It said the risk of infection is likely low but it decided to take a conservative approach.

The company cut its earnings outlook on Tuesday as it announced the recall, and its shares sank nearly 9 percent.

Earlier in the year, Bausch & Lomb conducted a recall of one of its contact lens solutions after it became associated with a severe fungal infection. In May, Bausch & Lomb decided to permanently discontinue its ReNu with MoistureLoc contact lens solution after hundreds of cases of an eye fungus were linked to the product.

Of the 2.9 million units being recalled worldwide, about 183,000 units made it into the U.S. Affected U.S. units account for less than one percent of Complete MoisturePlus' annual sales. The company booked about $208.6 million, or about 28 percent of total sales, from eye care product sales for the first nine months of 2006.

The company said it will suspend production at its plant in China for about 10 to 12 weeks.

Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo